![Lefamulin efficacy and safety in a pooled phase 3 clinical trial population with community-acquired bacterial pneumonia and common clinical comorbidities | BMC Pulmonary Medicine | Full Text Lefamulin efficacy and safety in a pooled phase 3 clinical trial population with community-acquired bacterial pneumonia and common clinical comorbidities | BMC Pulmonary Medicine | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12890-021-01472-z/MediaObjects/12890_2021_1472_Fig1_HTML.png)
Lefamulin efficacy and safety in a pooled phase 3 clinical trial population with community-acquired bacterial pneumonia and common clinical comorbidities | BMC Pulmonary Medicine | Full Text
![Lefamulin (Xenleta) for the Treatment of Community-Acquired Bacterial Pneumonia - STEPS - American Family Physician Lefamulin (Xenleta) for the Treatment of Community-Acquired Bacterial Pneumonia - STEPS - American Family Physician](https://www.aafp.org/afp/2020/0915/afp20200915-cover.jpg)
Lefamulin (Xenleta) for the Treatment of Community-Acquired Bacterial Pneumonia - STEPS - American Family Physician
![Lefamulin efficacy and safety in a pooled phase 3 clinical trial population with community-acquired bacterial pneumonia and common clinical comorbidities | BMC Pulmonary Medicine | Full Text Lefamulin efficacy and safety in a pooled phase 3 clinical trial population with community-acquired bacterial pneumonia and common clinical comorbidities | BMC Pulmonary Medicine | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12890-021-01472-z/MediaObjects/12890_2021_1472_Fig3_HTML.png)